Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7237 results

Sort By:

PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer

Study ID: NCT06074510
Start Date: 2024-02-08
End Date: 2026-11
Study Type

Interventional

Study Phase

Phase4

No. of Participants

274

Intervention / Treatment

Piflufolastat F 18 Intravenous Solution [PYLARIFY]

Sponsor

Lantheus Medical Imaging

Source: clinicaltrials.gov

Share:
Add to list

The Effect of Diet and Exercise on ImmuNotherapy and the Microbiome (EDEN)

Study ID: NCT04866810
Start Date: 2023-07-25
End Date: 2026-10-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Intervention Arm

Control

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

Study ID: NCT00005095
Start Date: 2000-03
End Date: 2040-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

6000

Intervention / Treatment

Ca-125

screening questionnaire administration

Surgery

Sponsor

Northwestern University

Source: clinicaltrials.gov

Share:
Add to list

Avo In R/R And Previously Untreated MCL

Study ID: NCT04855695
Start Date: 2021-07-02
End Date: 2026-06-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

53

Intervention / Treatment

Acalabrutib

Venetoclax

Obinutuzumab

Sponsor

Austin I Kim

Source: clinicaltrials.gov

Share:
Add to list

Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma

Study ID: NCT06070012
Start Date: 2025-03-10
End Date: 2030-03-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

44

Intervention / Treatment

Tebentafusp

Sponsor

Diwakar Dawar

Source: clinicaltrials.gov

Share:
Add to list

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

Study ID: NCT05765812
Start Date: 2023-05-15
End Date: 2028-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

116

Intervention / Treatment

Debio 0123

Temozolomide

Radiotherapy

Sponsor

Debiopharm International SA

Source: clinicaltrials.gov

Share:
Add to list

VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors

Study ID: NCT04796012
Start Date: 2023-04-18
End Date: 2027-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

23

Intervention / Treatment

Atezolizumab

Vincristine

Irinotecan

Temozolomide

Sponsor

University of Texas Southwestern Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy

Study ID: NCT05020912
Start Date: 2021-12-13
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

28

Intervention / Treatment

ALA

PDT

Sponsor

Case Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Encorafenib Plus Binimetinib for People With BRAF V600 Mutated Relapsed/Refractory HCL

Study ID: NCT04324112
Start Date: 2020-10-28
End Date: 2028-07-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

45

Intervention / Treatment

binimetinib

Encouragenib

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer

Study ID: NCT05491512
Start Date: 2022-08-04
End Date: 2025-08-04
Study Type

Interventional

Study Phase

Phase2

No. of Participants

121

Intervention / Treatment

18 F-FMISO PET/CT

Radiation

Cisplatin

Carboplatin

5-fluorouracil

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list